Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innoviva (INVA) Other Working Capital Changes: 2010-2025

Historic Other Working Capital Changes for Innoviva (INVA) over the last 15 years, with Sep 2025 value amounting to $16.9 million.

  • Innoviva's Other Working Capital Changes rose 288.17% to $16.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.5 million, marking a year-over-year increase of 109.38%. This contributed to the annual value of $38.2 million for FY2024, which is 581.60% up from last year.
  • Per Innoviva's latest filing, its Other Working Capital Changes stood at $16.9 million for Q3 2025, which was up 1,312.88% from $1.2 million recorded in Q2 2025.
  • Over the past 5 years, Innoviva's Other Working Capital Changes peaked at $16.9 million during Q3 2025, and registered a low of -$14.8 million during Q3 2023.
  • Over the past 3 years, Innoviva's median Other Working Capital Changes value was -$5.4 million (recorded in 2023), while the average stood at -$3.7 million.
  • Its Other Working Capital Changes has fluctuated over the past 5 years, first tumbled by 1,552.83% in 2021, then soared by 480.78% in 2022.
  • Quarterly analysis of 5 years shows Innoviva's Other Working Capital Changes stood at -$770,000 in 2021, then surged by 480.78% to $2.9 million in 2022, then slumped by 605.80% to -$14.8 million in 2023, then soared by 39.45% to -$9.0 million in 2024, then spiked by 288.17% to $16.9 million in 2025.
  • Its Other Working Capital Changes stands at $16.9 million for Q3 2025, versus $1.2 million for Q2 2025 and -$5.6 million for Q1 2025.